VRPX Company Profile and Key Details
Virpax Pharmaceuticals, Inc.
VRPX Stock Price Chart
Stock Price Today
Virpax Pharmaceuticals, Inc. (VRPX) stock declined over -3.27%, trading at $0.28 on NASDAQ, down from the previous close of $0.29. The stock opened at $0.29, fluctuating between $0.28 and $0.29 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical nonsteroidal anti-inflammatory drug treatment for chronic osteoarthritis of the knee; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also comprise PES200, which enables the delivery of a metabolically labile peptide drug into the brain; AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and VRP324, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania.
Company Information
| Employees | 7 |
| Beta | 1.09 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) stock price is $0.28 in the last trading session. During the trading session, VRPX stock reached the peak price of $0.29 while $0.28 was the lowest point it dropped to. The percentage change in VRPX stock occurred in the recent session was -3.27% while the dollar amount for the price change in VRPX stock was -$0.01.
The NASDAQ listed VRPX is part of Biotechnology industry that operates in the broader Healthcare sector. Virpax Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Shana Panzarella
Chief of Staff
Mr. Christopher M. Chipman C.P.A., CPA
Executive Officer
Mr. Vinay Shah MBA
Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer
Mr. Anthony P. Mack M.B.A.
Chairman & Chief Executive Officer
Mr. Gerald W. Bruce
Executive Vice President of Commercial Operations & Director
Dr. Sheila A. Mathias J.D., M.B.A., Ph.D.
Chief Scientific Officer
Dr. Jeffrey A. Gudin M.D.
Executive Vice President, Chief Medical Officer & Director
Mr. Christopher M. Chipman CPA, CPA
Chief Financial Officer, Principal Accounting Officer & Corporation Sec.
Mr. Vinay Shah A.C.A., M.B.A., MBA
Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer
VRPX's closing price is 3.27% higher than its 52-week low of $0.28 where as its distance from 52-week high of $5.48 is -94.82%.
Number of VRPX employees currently stands at 7.
Official Website of VRPX is: https://www.virpaxpharma.com
VRPX could be contacted at phone 610 727 4597 and can also be accessed through its website. VRPX operates from 1055 Westlakes Drive, Berwyn, PA 19312, United States.
VRPX stock volume for the day was 265.78K shares. The average number of VRPX shares traded daily for last 3 months was 3.86M.
The market value of VRPX currently stands at $4.23M with its latest stock price at $0.28 and 14.89M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com